NCT04422145

Brief Summary

Patients who suffer hypoglycaemia in the community requiring the services of an ambulance are known to have a high short term mortality based on previous work. What is not known is the demographics of this group and also what the cause of death was for individuals whom unfortunately passed away in the time following ambulance callout. Importantly, studies looking at interventions to reduce poor outcomes in this group are lacking. The investigators conducted a pilot trial with the main goals to:

  1. 1.Characterise this group in more detail and ascertain what was recorded as cause of death in those whom passed away in the months/years following community hypoglycaemia
  2. 2.Ascertain if a simple nurse led intervention, focusing on educating participants on avoidance of hypoglycaemia, could improve outcome.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
323

participants targeted

Target at P75+ for not_applicable diabetes-mellitus

Timeline
Completed

Started Feb 2013

Longer than P75 for not_applicable diabetes-mellitus

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2013

Completed
4.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 18, 2017

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 18, 2018

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

May 13, 2020

Completed
27 days until next milestone

First Posted

Study publicly available on registry

June 9, 2020

Completed
Last Updated

June 9, 2020

Status Verified

June 1, 2020

Enrollment Period

4.9 years

First QC Date

May 13, 2020

Last Update Submit

June 4, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • All cause mortality at study endpoint with each participant having a minimum follow up of 12 months and the final analysis of data being done 58 months after the first participant was recruited (this is study endpoint.)

    Electronic review of participants records to ascertain if they had passed away during the study

    Through study endpoint, which was 58 months following the recruitment of the first participant and 12 months following the recruitment of the last participant.

Secondary Outcomes (3)

  • All cause mortality at 12 months from recruitment.

    12 months

  • Analyse cause of death at study endpoint (12 months following recruitment of last participant).

    Study end point defined as 12 months following recruitment of last participant (approximately 40 months from start of study).

  • Assessment of differences in mortality rate between type 1 and type 2 diabetes participants

    Study endpoint (12 months following recruitment of last participant.)

Study Arms (3)

Interventional/intensive

ACTIVE COMPARATOR

Participants received a structured nurse led education programme surrounding hypoglycaemia. They were encouraged to use self monitoring of blood glucose (SMBG) and had their diabetes medications adjusted according to this. They also received information on how to avoid hypoglycaemia (including the effects of diet, exercise, alcohol and their medications) and how to treat hypoglycaemia should it occur.

Behavioral: Structured nurse led intervention programme

Standard

PLACEBO COMPARATOR

Participants returned to their standard diabetes care provider with no intervention.

Other: Standard care

Observational

NO INTERVENTION

Participants were happy to have baseline characteristics collected and be followed up using electronic records in a longitudinal fashion but did not wish to be randomized. The observational and standard groups therefore received the same diabetes care.

Interventions

A diabetes research nurse, over a period of 12 months, provided a structured education programme to participants focussing on the avoidance of hypoglycaemia and the treatment of this if/when it occurred.

Interventional/intensive

Participants continue on their current diabetes care plan and are looked after by their usual diabetes care provider

Standard

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diabetes mellitus Can provide written informed consent

You may not qualify if:

  • Hypoglycaemia from cause not related to diabetes mellitus

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Diabetes centre, St James hospital

Leeds, West Yorkshire, LS97TF, United Kingdom

Location

Related Publications (1)

  • Pearson SM, Whittam B, Kulavarasalingam K, Mitchell-Gears A, James C, Ajjan RA. Reduction in cardiovascular mortality following severe hypoglycemia in individuals with type 2 diabetes: the role of a pragmatic and structured intervention : Structured intervention for community hypoglycemia. Cardiovasc Diabetol. 2021 Jan 12;20(1):18. doi: 10.1186/s12933-020-01204-3.

MeSH Terms

Conditions

Diabetes MellitusHypoglycemia

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Officials

  • Ramzi Ajjan, PHD

    Professor of metabolic medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Due to the nature of the intervention 9a nurse led education programme) it was not possible to mask participant or trial team to the intervention
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of metabolic medicine

Study Record Dates

First Submitted

May 13, 2020

First Posted

June 9, 2020

Study Start

February 1, 2013

Primary Completion

December 18, 2017

Study Completion

December 18, 2018

Last Updated

June 9, 2020

Record last verified: 2020-06

Data Sharing

IPD Sharing
Will not share

No plan to do so is currently in place. Of course once data is submitted if other researchers contact us we would consider providing data for the purpose of meta analysis

Locations